Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Endometriosis | Research

Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer

Authors: Huimin Wang, Cong Chen, Danbo Wang, Yanmei Zhu, Peng Chen

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

The main aim of this study was to establish the clinicopathological and prognostic correlations between endometriosis-associated and non-endometriosis-associated primary ovarian cancer, with a view to providing a reference guide for revision of diagnostic criteria for malignant transformation of endometriosis.

Methods

Clinicopathological and follow-up data of 174 patients with clear cell and endometrial ovarian cancer were retrospectively extracted. Cases were divided into endometriosis-associated and non-endometriosis-associated primary ovarian cancer for comparative analysis of clinicopathological characteristics and prognosis.

Results

Average age and post-menopausal rate in the endometriosis-associated ovarian cancer group were lower relative to the primary ovarian cancer group (P < 0.05). Body mass index, age at menopause, operation history, dysmenorrhea, complications, tumor size, tumor side, ascites, CA125, HE4, CA19.9, stage, differentiation, expression of ER, PR, P53, P16, Ki67, MMR, HNF-1β and Napsin A were not significantly different between the groups (P > 0.05). Furthermore, rates of resistance to platinum chemotherapy, relapse, progression-free survival and overall survival were comparable between the two groups (P > 0.05).

Conclusion

Endometriosis-associated and primary ovarian cancers of the same pathological type are speculated to be homologous in terms of origin from malignant transformation of endometriosis. It may therefore be necessary to revise the diagnostic criteria for ovarian endometriosis malignancy.
Literature
2.
go back to reference Erzen M, Rakar S, Klancnik B, Syrjänen K. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol. 2001;83:100–8.CrossRefPubMed Erzen M, Rakar S, Klancnik B, Syrjänen K. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol. 2001;83:100–8.CrossRefPubMed
3.
go back to reference Sampson J. Endometrial carcinoma of the ovary arising in endo metrial tissue in that organ. Arch Surg. 1925;10:1–72.CrossRef Sampson J. Endometrial carcinoma of the ovary arising in endo metrial tissue in that organ. Arch Surg. 1925;10:1–72.CrossRef
4.
go back to reference Scott R. Malignant change in endometriosis. Obstet Gynecol. 1953;2:293–9. Scott R. Malignant change in endometriosis. Obstet Gynecol. 1953;2:293–9.
5.
go back to reference Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci. 2002;955:281–92.CrossRefPubMed Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci. 2002;955:281–92.CrossRefPubMed
6.
go back to reference Gadducci A, Lanfredini N, Tana R. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma. Gynecol Endocrinol. 2014;30:612–7.CrossRefPubMed Gadducci A, Lanfredini N, Tana R. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma. Gynecol Endocrinol. 2014;30:612–7.CrossRefPubMed
7.
go back to reference Vercellini P, Viganò P, Buggio L, Makieva S, Scarfone G, Cribiù FM, et al. Perimenopausal management of ovarian endometriosis and associated cancer risk: when is medical or surgical treatment indicated?Best practice and research. Clin Obstet Gynaecol. 2018;51:151–68. Vercellini P, Viganò P, Buggio L, Makieva S, Scarfone G, Cribiù FM, et al. Perimenopausal management of ovarian endometriosis and associated cancer risk: when is medical or surgical treatment indicated?Best practice and research. Clin Obstet Gynaecol. 2018;51:151–68.
8.
go back to reference Bas-Esteve E, Pérez-Arguedas M, Guarda-Muratori GA, Acién M, Acién P. Endometriosis and ovarian cancer:their association and relationship. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100053.PubMedPubMedCentral Bas-Esteve E, Pérez-Arguedas M, Guarda-Muratori GA, Acién M, Acién P. Endometriosis and ovarian cancer:their association and relationship. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100053.PubMedPubMedCentral
9.
go back to reference Mallen A, Soong TR, Townsend MK, Wenham RM, Crum CP, Tworoger SS. Surgical prevention strategies in ovarian cancer. Gynecol Oncol. 2018;151:166–75.CrossRefPubMed Mallen A, Soong TR, Townsend MK, Wenham RM, Crum CP, Tworoger SS. Surgical prevention strategies in ovarian cancer. Gynecol Oncol. 2018;151:166–75.CrossRefPubMed
10.
go back to reference Ren F, Wang D, Jiang Y, Ren F. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis. Arch Gynecol Obstet. 2012;285:215–21.CrossRefPubMed Ren F, Wang D, Jiang Y, Ren F. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis. Arch Gynecol Obstet. 2012;285:215–21.CrossRefPubMed
11.
go back to reference Guo C, Ren F, Wang D, Li Y, Liu K, Liu S, et al. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis. Oncol Rep. 2014;32:2580–8.CrossRefPubMed Guo C, Ren F, Wang D, Li Y, Liu K, Liu S, et al. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis. Oncol Rep. 2014;32:2580–8.CrossRefPubMed
12.
go back to reference Samartzis EP, Labidi-Galy SI, Moschetta M, Uccello M, Kalaitzopoulos DR, Perez-Fidalgo JA, et al. Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review. Ann Transl Med. 2020;8:1712.CrossRefPubMedPubMedCentral Samartzis EP, Labidi-Galy SI, Moschetta M, Uccello M, Kalaitzopoulos DR, Perez-Fidalgo JA, et al. Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review. Ann Transl Med. 2020;8:1712.CrossRefPubMedPubMedCentral
13.
go back to reference Wang S, Qiu L, Lang JH, Shen K, Yang JX, et al. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis. Am J Obstet Gynecol. 2013;208:411–5.CrossRef Wang S, Qiu L, Lang JH, Shen K, Yang JX, et al. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis. Am J Obstet Gynecol. 2013;208:411–5.CrossRef
14.
go back to reference Chen S, Dai X, Gao Y, Shen F, Ding J, Chen Q. The positivity of estrogen receptor and progesterone receptor may not be associated with Metastasis and recurrence in epithelial ovarian cancer. Sci Rep. 2017;7:16922.CrossRefPubMedPubMedCentral Chen S, Dai X, Gao Y, Shen F, Ding J, Chen Q. The positivity of estrogen receptor and progesterone receptor may not be associated with Metastasis and recurrence in epithelial ovarian cancer. Sci Rep. 2017;7:16922.CrossRefPubMedPubMedCentral
15.
go back to reference Ip PPC, Wang SY, Wong OGW, Chow KL, Lee HHY, Cheung ANY, et al. Napsin A, Hepatocyte nuclear factor-1-beta (HNF-1β), estrogen and progesterone receptors expression in Arias-Stella reaction. Am J Surg Pathol. 2019;2019(43):325–33.CrossRef Ip PPC, Wang SY, Wong OGW, Chow KL, Lee HHY, Cheung ANY, et al. Napsin A, Hepatocyte nuclear factor-1-beta (HNF-1β), estrogen and progesterone receptors expression in Arias-Stella reaction. Am J Surg Pathol. 2019;2019(43):325–33.CrossRef
16.
go back to reference Bennett Ja, Morales-Oyarvide V, Campbell S, Longacre TA, Oliva E. Mismatch repair protein expression in clear cell carcinoma of the ovary: incidence and morphologic associations in 109 cases. Am J Surg Pathol. 2016;40:656–63.CrossRefPubMed Bennett Ja, Morales-Oyarvide V, Campbell S, Longacre TA, Oliva E. Mismatch repair protein expression in clear cell carcinoma of the ovary: incidence and morphologic associations in 109 cases. Am J Surg Pathol. 2016;40:656–63.CrossRefPubMed
17.
go back to reference Munjishvili V, Barabadze E, Musashvili T, Gachechiladze M, Burkadze G. Morphophenotypic characteristics of ovarian serous borderline tumors. Georgian Med News. 2019;290:20–5. Munjishvili V, Barabadze E, Musashvili T, Gachechiladze M, Burkadze G. Morphophenotypic characteristics of ovarian serous borderline tumors. Georgian Med News. 2019;290:20–5.
18.
go back to reference Suzuki F, Akahira JI, Akahira I, Miura T, Suzuki K, Ito K, Hayashi SI, et al. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5’-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 2008;99:2365–72.CrossRefPubMed Suzuki F, Akahira JI, Akahira I, Miura T, Suzuki K, Ito K, Hayashi SI, et al. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5’-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 2008;99:2365–72.CrossRefPubMed
19.
go back to reference Tanase Y, Yamada Y, Shigetomi H, Kajihara H, Oonogi A, Yoshizawa Y, et al. Modulation of estrogenic action in clear cell carcinoma of the ovary. Exp Ther Med. 2012;3:18–24.CrossRefPubMed Tanase Y, Yamada Y, Shigetomi H, Kajihara H, Oonogi A, Yoshizawa Y, et al. Modulation of estrogenic action in clear cell carcinoma of the ovary. Exp Ther Med. 2012;3:18–24.CrossRefPubMed
20.
go back to reference Ren T, Wang S, Sun J, Qu JM, Xiang Y, Shen K, et al. Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma. J Ovarian Res. 2017;10:67.CrossRefPubMedPubMedCentral Ren T, Wang S, Sun J, Qu JM, Xiang Y, Shen K, et al. Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma. J Ovarian Res. 2017;10:67.CrossRefPubMedPubMedCentral
21.
go back to reference Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer. 2018;28:11–8.CrossRefPubMed Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer. 2018;28:11–8.CrossRefPubMed
22.
go back to reference Li Q, Sun Y, Zhang X, Wang L, Wu W, Meng C, et al. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics. Cancer Biol Ther. 2019;20:1029–34.CrossRefPubMedPubMedCentral Li Q, Sun Y, Zhang X, Wang L, Wu W, Meng C, et al. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics. Cancer Biol Ther. 2019;20:1029–34.CrossRefPubMedPubMedCentral
23.
go back to reference Zhao T, Shao Y, Liu Y, Wang X, Guan L, Lu Y. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute. J Ovarian Res. 2018;11:53.CrossRefPubMedPubMedCentral Zhao T, Shao Y, Liu Y, Wang X, Guan L, Lu Y. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute. J Ovarian Res. 2018;11:53.CrossRefPubMedPubMedCentral
24.
go back to reference Hermens M, van Altena AM, van der Aa M, Bulten J, van Vliet HAAM, Siebers AG, et al. Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 women. Am J Obstet Gynecol. 2021;224:284.e1-284.e10.CrossRefPubMed Hermens M, van Altena AM, van der Aa M, Bulten J, van Vliet HAAM, Siebers AG, et al. Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 women. Am J Obstet Gynecol. 2021;224:284.e1-284.e10.CrossRefPubMed
25.
go back to reference Moufarrij S, Dandapani M, Arthofer E, Gomez S, Srivastava A, Lopez-Acevedo M, et al. Epigenetic therapy for ovarian cancer: promise and progress. Clin Epigenetics. 2019;11:7.CrossRefPubMedPubMedCentral Moufarrij S, Dandapani M, Arthofer E, Gomez S, Srivastava A, Lopez-Acevedo M, et al. Epigenetic therapy for ovarian cancer: promise and progress. Clin Epigenetics. 2019;11:7.CrossRefPubMedPubMedCentral
Metadata
Title
Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer
Authors
Huimin Wang
Cong Chen
Danbo Wang
Yanmei Zhu
Peng Chen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11641-4

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine